Rizatriptan Benzoate Tablet
Product Images NDC 68462-466

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Rizatriptan Benzoate (NDC 68462-466). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton-10mg (Carton 10mg)

Carton-10mg (Carton 10mg)
This text is a drug label for Rizatriptan Benzoate tablets manufactured by Glenmark Pharmaceuticals Inc., USA. The tablets are for oral use and are only available with a prescription. The usual dosage is advised to be followed as per the accompanying circular. The package is not child-resistant and should be kept out of reach of children. The tablets should be stored at controlled room temperature. The label provides the manufacturer's details, lot number, and size of tablets (18 unit-dose tablets).*
FDA Label Image

Carton-5mg (Carton 5mg)

Carton-5mg (Carton 5mg)
This is a description of Glenmark's Rizatriptan Benzoate Tablets, an Rx Only medicine that comes in a unit-dose package containing 18 tablets. Each tablet contains 7.265 mg of Rizatriptan benzoate USP, equivalent to 6 mg of Rizatriptan. The text includes instructions on the recommended dosage and storage conditions. The product may not be child-resistant, and it is essential to keep it out of reach of children. The manufacturer is Glenmark Pharmaceuticals, and the product is a product of India. The accompanying circular provides more information.*
FDA Label Image

Chemical-structure (Chemical Structure)

FDA Label Image

Figure1 (Figure1)

FDA Label Image

Figure2 (Figure2)

Figure2 (Figure2)
This appears to be a graph showing estimated probability of remedication or rescue at different time points post dose. The x-axis shows hours post-dose and the y-axis represents probability in percentages. However, the graph seems to have some ocr errors and is unclear in some sections.*
FDA Label Image

Figure3 (Figure3)

FDA Label Image

Figure4 (Figure4)

FDA Label Image

Figure5 (Figure5)

FDA Label Image
FDA Label Image

Glenmark-logo1 (Glenmark Logo1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.